Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming / USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion / Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years / Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percentage accretion in the third full year / Committed to retaining strong presence in the U.S. with the combined business’ global Seeds & Traits and North American commercial headquarters in St. LouisEn savoir plus
Group sales increase by 2.3 percent (Fx & portfolio adj.) to EUR 11,833 million / Pharmaceuticals continues strong growth trend / Consumer Health increases sales / Crop Science business holds steady in a continuingly difficult market environment / EBITDA before special items up 5.7 percent to EUR 3,054 million / Net income improves by 18.6 percent to EUR 1,380 million / Core earnings per share increase by 4.0 percent to EUR 2.07 / Group forecast raisedEn savoir plus
Joint white paper, released at United Nations High Level Political Forum, outlines key policy changes to address self-care barriersat the global, national and local level Bayer commits $1.3M in programs and services;
three-year commitment to help women and children in developing countriesEn savoir plus
Diegem, le 12 juillet 2016 - Bayer, en partenariat avec l’Agence internationale pour la prévention de la cécité (IAPB), lance un concours international de photo pour la deuxième année consécutive. Cette année, le thème est #StrongerTogether. Le concours est organisé dans le cadre de la Journée mondiale de la vue, qui se tiendra le 13 octobre, et attire l'attention sur l'importance de la santé oculaire.
En savoir plus
Monsanto all-cash offer increased to USD 125 per share on July 1 after additional information received in private discussions / Bayer has comprehensively addressed Monsanto’s questions concerning financing of the transaction / In addition to certain commitments to regulators possibly required, Bayer has offered a USD 1.5 billion reverse antitrust break fee, reaffirming its confidence to successfully close / The revised offer retains compelling value creation potential for Bayer shareholders / Bayer remains fully committed to pursuing this transactionEn savoir plus